Skip to content
★ Sign in to follow
RP

Raymond Pawlicki

Executive
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€4.0M

Latest filing published 25 Nov 2013 for BIOGEN INC., €148k.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

Raymond Pawlicki: trading record in brief

Raymond Pawlicki is a declared insider of Biogen Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 3 May 2012 to 22 November 2013, the count stands at 18 filings.

The open-market record consists of 5 sales worth €4.0M, with no purchase. Besides market trades, the filings include 6 share grants and 7 option exercises. 2013 to date brings no purchases and 3 sales.

The newest entry dates from 25 November 2013: an option exercise of €148k, in Biogen Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Raymond Pawlicki

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    199,800 USD0SEC
    4,000 shares@ US$49.95Common StockSEC:0001127602-13-032763:0
  • ▼
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    1M USD0SEC
    4,000 shares@ US$288.00Common StockSEC:0001127602-13-032763:1
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    198,360 USD0SEC
    4,000 shares@ US$49.59Common StockSEC:0001127602-13-027467:0
  • ▼
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    952,120 USD0SEC
    4,000 shares@ US$238.03Common StockSEC:0001127602-13-027467:1
  • ◆
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    189,524 USD0SEC
    866 shares@ US$218.85Common StockSEC:0001127602-13-015895:0
  • ◆
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    106,281 USD0SEC
    630 shares@ US$168.70Common StockSEC:0001127602-13-009050:0
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    0SEC
    1,529 shares0Common StockSEC:0001127602-13-007946:0
  • ◆
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    118,697 USD0SEC
    722 shares@ US$164.40Common StockSEC:0001127602-13-007946:1
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    0SEC
    1,106 shares0Common StockSEC:0001127602-13-005645:0
  • ◆
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    86,002 USD0SEC
    523 shares@ US$164.44Common StockSEC:0001127602-13-005645:1
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    0SEC
    1,890 shares0Common StockSEC:0001127602-13-005645:2
  • ◆
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    146,845 USD0SEC
    893 shares@ US$164.44Common StockSEC:0001127602-13-005645:3
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    496,500 USD0SEC
    10,000 shares@ US$49.65Common StockSEC:0001127602-13-004641:0
  • ▼
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    2M USD0SEC
    10,000 shares@ US$165.55Common StockSEC:0001127602-13-004641:1
  • ◇
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    495,900 USD0SEC
    10,000 shares@ US$49.59Common StockSEC:0001127602-12-020527:0
  • ▼
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    1M USD0SEC
    10,000 shares@ US$143.00Common StockSEC:0001127602-12-020527:1
  • ▼
    SVP, Chief Information OfficerExecutivesBiogen Inc.
    135,049 USD0SEC
    1,068 shares@ US$126.45Common StockSEC:0001127602-12-019276:0

17 of 17 declarations